Lactoferrin: The ultimate all-purpose protein.

1. Introduction to Lactoferrin

Lactoferrin is a multifunctional glycoprotein belonging to the transferrin family, primarily recognized for its iron-binding capacity and its role in the immune response. It was initially discovered in bovine milk in 1939 by Sørensen, while its presence in human milk was confirmed in 1960 by researcher Murray [1-3]. In addition to being found in milk, this protein is present in other bodily fluids such as saliva, tears, and nasal secretions, suggesting an essential role in protecting mucosal barriers and in the body's innate immunity [4-6].

Since its discovery, lactoferrin has been extensively researched for its immunomodulatory, antimicrobial, antioxidant, and even antitumor properties , with growing interest in its potential for treating bacterial and viral infections, as well as its role as an adjuvant in cancer therapies (Figure 1) [7-9]. This protein is key in regulating iron in the human body, as its ability to bind to this mineral limits its availability to pathogenic microorganisms, creating a less favorable environment for their growth and thus reducing the likelihood of infections [10-12]. Lactoferrin has been referred to as a "miracle molecule " in some studies due to the variety of therapeutic benefits it offers, making it a subject of interest in modern medicine [13].

2. Molecular Structure and Properties

Lactoferrin is a protein of approximately 80 kDa composed of 691 amino acids in humans and 689 in the bovine version. The molecular structure of lactoferrin is divided into two lobes, known as N and C, which are connected by a short α-helix [14-16]. Each of these lobes possesses two specific domains that allow the binding of iron ions ( Fe³⁺ ), a fundamental characteristic for its antioxidant and antimicrobial function . Lactoferrin's ability to bind iron not only restricts the availability of this mineral in the body but also contributes to its role as a modulator in inflammatory processes [17-19].

Molecular Variants and Iron Saturation
Lactoferrin exists in three main molecular forms, which vary according to their iron saturation: apolactoferrin (iron-free), native lactoferrin (with a natural iron saturation of 10-20%), and hololactoferrin (with an iron saturation close to 100%). These variants differ not only in their affinity for and ability to bind iron , but also in their biological properties and therapeutic applications .

a) Apolactoferrin

Apolactoferrin is the unsaturated form of lactoferrin, meaning it lacks iron in its structure. This variant is particularly useful in situations where iron uptake may be beneficial. Apolactoferrin is used in the prevention and treatment of bacterial infections due to its ability to sequester the iron necessary for bacterial proliferation, creating an environment inhospitable to bacterial growth [1-3]. This property makes it a useful option for treating intestinal infections and preventing bacterial biofilms on medical devices. Furthermore, apolactoferrin has shown potential in modulating the immune system, helping to reduce inflammation by regulating pro-inflammatory cytokines, and is therefore being investigated in the context of inflammatory and autoimmune diseases [4].

b) Hololactoferrin

Hololactoferrin is the form of lactoferrin that is fully saturated with iron . Due to its high saturation, hololactoferrin has superior stability in acidic environments and is less effective at sequestering iron compared to apolactoferrin. However, studies have shown that hololactoferrin has protective effects on the intestinal mucosa and can promote cell regeneration, which is useful in gastrointestinal diseases such as colitis and irritable bowel syndrome [5-7]. Hololactoferrin has also shown antioxidant effects due to its stability in adverse physiological environments, protecting cells from oxidative stress and reducing cell damage, giving it potential applications in aging and chronic diseases [8].

c) Native Lactoferrin

Native lactoferrin, which contains approximately 10–20% iron saturation , is the most widely used form therapeutically due to its balanced antimicrobial, immunomodulatory, and antioxidant properties. This level of saturation allows native lactoferrin to act both in iron uptake when needed and in stabilizing cells and tissues in diverse physiological environments. Native lactoferrin has a higher affinity for free iron and is able to adapt to the body's needs, sequestering or releasing iron depending on local conditions [9–11].

Native lactoferrin, with its partial iron saturation, offers unique versatility that makes it ideal for various therapeutic applications. Its balance between iron binding and release allows it to adapt to the body's needs , offering benefits in antimicrobial defense, immune support, and cellular protection [17, 18, 24]. These characteristics make native lactoferrin a key component in the formulation of supplements and therapies for infectious, immunological, and oncological diseases, and it is the preferred variant in clinical studies due to its efficacy and safety in human applications [19, 25, 24].

3. Metabolism, Absorption and Distribution

The bioavailability of lactoferrin in the human body is crucial for understanding its effectiveness and therapeutic applications. When administered orally, this protein must pass through several stages in the digestive system before reaching the bloodstream. Lactoferrin absorption occurs primarily in the small intestine , where it is transported across enterocytes that express specific receptors for this protein, facilitating its efficient and selective absorption [23-25]. This specificity is important because it ensures that lactoferrin maintains its biological activity in the body.

An important characteristic of lactoferrin is its partial resistance to degradation in the acidic environment of the stomach. This capacity is due to its molecular structure, which allows a significant fraction of lactoferrin to remain intact as it passes through the stomach, thus ensuring its arrival in the intestine, where it can be adequately absorbed [23-25]. This is crucial because, if it were to break down in the stomach, its bioavailability and, consequently, its therapeutic benefits would be significantly reduced. Therefore, selecting an appropriate pharmaceutical form and an optimized formulation is fundamental for its supplementation. Studies have shown that an effective formulation can increase the bioavailability of lactoferrin to values ​​close to 95%, maximizing its stability, absorption, and effectiveness in the body, and enhancing its properties.

In neonates , lactoferrin bioavailability is considerably higher compared to adults. This is due to the immaturity of their digestive system, which allows for more efficient absorption of intact proteins. This high bioavailability in the first years of life suggests that lactoferrin plays a fundamental role in the early development of the immune system , providing additional defense against pathogens at a stage when the immune system is still developing [26-28].

Once lactoferrin enters the bloodstream, it is distributed through the lymphatic system , reaching various tissues and organs throughout the body. However, the bioavailability of this protein tends to decrease with age . In older adults, reduced lactoferrin absorption may also contribute to a decline in its immunomodulatory effects, highlighting the importance of bioavailability for its therapeutic efficacy [29-31].

The elimination of lactoferrin from the body occurs predominantly through the liver , where hepatocytes and Kupffer cells play an essential role in its degradation and recycling. This process ensures that lactoferrin levels in the body remain in balance. Other organs, such as the spleen and kidneys , also participate in its elimination, contributing to the regulation of its levels in the body and ensuring that excessive amounts of this protein do not accumulate, which could disrupt its physiological balance [32].

This journey through the digestive system, absorption in the intestine, transport in the lymphatic system, and subsequent elimination via the liver, spleen, and kidneys reflects the complexity of lactoferrin metabolism in the body. These processes are essential to maximize its therapeutic effects and ensure its functionality as an immunomodulatory, antimicrobial, and antioxidant agent in various clinical applications.

4. Therapeutic Applications of Lactoferrin

Lactoferrin is a highly versatile molecule with prominent applications in various clinical areas. Its immunomodulatory, antimicrobial, antiviral, antioxidant, and antitumor properties allow it to act on different fronts of health, providing support in both the prevention and treatment of multiple pathologies. This protein not only strengthens the body's defenses by modulating the immune system but also plays a role in the elimination of pathogens and the protection of cells against oxidative damage. Its ability to adapt and contribute to such varied processes positions it as an ideal candidate in the development of treatments for infections, chronic diseases, and even as an adjuvant in cancer therapies [7,18,20,25,27].

Immunomodulation and Regulation of the Immune Response

Lactoferrin modulates both the innate and adaptive immune responses . Its effects are due to its ability to influence the expression of proinflammatory cytokines , such as IL-6 and IL-1β, and to promote the differentiation and activation of immune cells such as T and B lymphocytes [33-35]. This immune balance is essential for reducing the risk of autoimmune and chronic inflammatory diseases, without compromising the body's ability to respond effectively to infections [36-38].

Recent studies have shown that lactoferrin can reduce viral replication in host cells in experimental infections, suggesting its potential use as an immunomodulator in patients with weakened immune systems [39-40]. Administration of lactoferrin in animal models has shown a decrease in inflammatory cytokine levels and an improved immune response, supporting its use in immunotherapy [41].

Antibacterial Properties and Effectiveness in Chronic Infections

The antibacterial activity of lactoferrin is one of the most studied aspects of this protein. It acts by sequestering iron , which is essential for the growth of many bacteria . Furthermore, its ability to bind to lipopolysaccharide (LPS) in Gram-negative bacteria destabilizes their membrane , facilitating the action of other immune defenses, such as lysozyme [42-44]. Lactoferrin has been shown to be effective against E. coli , S. aureus , and other bacteria common in chronic infections [45].

Lactoferrin also inhibits biofilm formation , a strategy used by bacteria to protect themselves and persist in chronic infections. This effect is particularly useful in difficult-to-treat infections, such as those associated with medical devices, where biofilm formation is a major cause of treatment failure (Figure 2)[46-48].

Figure 2 : Different antibacterial actions of LF.

Antiviral Activity and Applications in Virology

Lactoferrin is effective against a variety of viruses , including HIV, hepatitis C virus, and influenza virus. By binding to heparan sulfate proteoglycans (HSPGs) in host cells, lactoferrin blocks the entry of these viruses, preventing their replication and spread [49-51]. In preclinical studies, lactoferrin has shown preventive effects against SARS-CoV-2 infection, suggesting a potential role in managing viral pandemics [52].

In addition, lactoferrin enhances the action of conventional antiviral treatments , making them more effective and allowing lower doses, which minimizes side effects (Figure 3) [53].

Figure 3 : Schematic representation of the antiviral function of LF.

Regulation of Glucose Metabolism and Insulin Resistance

Lactoferrin has shown promising results in improving insulin sensitivity and regulating blood glucose levels. This is attributed to its ability to inhibit inflammatory pathways such as TLR-4-NF-κB and activate SIRT-1, thereby reducing systemic inflammation associated with type 2 diabetes [54-56]. Furthermore, it facilitates glucose transport to the epithelial cells of the small intestine via the SGLT1 transporter, helping to control hyperglycemia without interfering with nutrient absorption [57-59].

Clinical trials in patients with metabolic syndrome have shown significant improvements in fasting glucose levels and insulin sensitivity following lactoferrin supplementation [60]. These effects position lactoferrin as a viable candidate in the management of diabetes and related metabolic disorders.

Iron Homeostasis and Cellular Protection

The role of lactoferrin in regulating iron allows it to reduce the toxicity associated with excessive iron accumulation , thus preventing the formation of free radicals and protecting cells from oxidative stress [61-63]. Lactoferrin contributes to so-called "nutritional immunity" by decreasing the availability of iron to pathogens such as bacteria and fungi, hindering their proliferation [64-65].

Furthermore, according to a recent study by El Amrousy D, El-Afify D, Elsawy A, et al., lactoferrin can also be used in the treatment of iron deficiency anemia by contributing to the normalization of serum levels of IL-6 and hepcidin, the main regulators of systemic iron balance , helping to restore adequate iron levels in the body.

Prevention of Mitochondrial Damage and Cellular Health

Lactoferrin helps maintain mitochondrial health by reducing the accumulation of reactive oxygen species (ROS), thereby protecting mitochondrial DNA and preventing cellular deterioration associated with neurodegenerative diseases and premature aging [66-68]. Its role as a mitochondrial antioxidant helps preserve the energy capacity of cells, reducing chronic inflammation and promoting longevity (Figure 4) [69].

Figure 4 : Key role of LF in mitochondrial health.

Oncological Applications

Lactoferrin has shown promising effects in oncology by inhibiting tumor cell proliferation and promoting apoptosis . In preclinical studies, it has been shown to act on the tumor microenvironment, modifying it to make it less favorable for malignant cell growth [27, 30, 40]. Furthermore, lactoferrin acts as an adjuvant in chemotherapy , increasing treatment tolerance and reducing side effects such as immunosuppression and damage to healthy tissues [69, 70-72].

Maternal and Child Health Benefits

In newborns and children, lactoferrin plays an essential role in the development of the immune system and in defense against infections, being especially beneficial in premature infants , who have greater immunological vulnerability [29, 36, 45]. This protein helps strengthen the body's first lines of defense and modulate immune responses, which is fundamental in the early stages of life. Likewise, in pregnant women, lactoferrin significantly contributes to improving iron absorption , a critical mineral during pregnancy. This not only protects the mother from potential infections and anemia, but also safeguards the fetus, promoting proper development , particularly in bone formation and the strengthening of its immune system during gestation [50, 57, 61].

5. Indications and Precautions for Clinical Use

Although lactoferrin is generally a safe and well-tolerated molecule, there are some important precautions to consider in specific health contexts. In individuals with hemochromatosis , a genetic condition characterized by iron overload, lactoferrin consumption may be counterproductive, as this protein facilitates iron absorption, which could exacerbate the excess iron and increase the risk of adverse effects, including liver damage and other associated problems [69-71]. Similarly, in people with pancreatitis , an inflammatory disease of the pancreas, lactoferrin supplementation may not be advisable, as it could influence iron dynamics and worsen inflammation of the pancreatic tissues, intensifying the symptoms and complications of this condition [72].

Furthermore, in individuals with lactose intolerance , it is advisable to select lactoferrin formulations that are completely lactose-free . Although lactoferrin itself does not contain lactose, some commercial preparations may contain traces, which could trigger unwanted gastrointestinal symptoms in sensitive individuals. Opting for lactose-free lactoferrin allows these individuals to benefit from the immunomodulatory, antimicrobial, and antioxidant properties of this protein without experiencing adverse effects [66,73]. These precautions underscore the importance of supervised lactoferrin administration in specific medical contexts to ensure its safety and effectiveness.

Conclusion

Lactoferrin is a protein with broad potential applications due to its immunomodulatory, antimicrobial, antioxidant, and antitumor properties. Its ability to regulate the immune response and control iron homeostasis makes it a promising agent in both preventive medicine and complementary therapy. Current research supports its use in the treatment of chronic infections and as an adjunct to cancer therapies, with studies also suggesting benefits in insulin resistance and metabolic syndrome.

In conclusion, lactoferrin represents a versatile therapeutic tool in precision medicine. Future clinical trials will help confirm its role in the treatment of infectious, metabolic, and oncological diseases.

Lactoferrin Pure Powder

It is presented as a very versatile therapeutic option with an iron saturation level of between 14-20%.

Its innovative powder format allows the physician to regulate the dosage and adapt it to any type of patient.

It is a product suitable for everyone due to its safety and ease of consumption. Furthermore, it is completely lactose-free .

Literature

Bibliographic References

1.      Sørensen SPL, Sørensen LM. Isolation of milk protein. Lait. 1939;19:351–6.

2.      Johansson JM. Identification of lactoferrin in human milk. Science. 1960;131(3402):1555–7.

3.      Sánchez L, Calvo M, Brock JH. Biochemistry of lactoferrin. Iron Metab Rev. 1992;12(3):317-28.

4.      Giansanti F, Panella G, Leboffe L, Antonini G. Lactoferrin from milk: Nutritional and functional aspects. Int J Mol Sci. 2016;17(12):1-15.

5.      Legrand D, Mazurier J. Lactoferrin: A key molecule in immune and inflammatory processes. J Am Coll Nutr. 1999;18(5 Suppl):435S-441S.

6.      Levay PF, Viljoen M. Lactoferrin: A general review. Haematology. 1995;80(2):252-67.

7.      Baveye-Descamps S, Chihib NE, Dang TH, et al. Antibacterial properties of lactoferrin and its effects on bacterial growth inhibition. J Appl Microbiol. 2021;131(5):2166-83.

8.      Fillebeen C, Ruchoux MM, Mitchell V, et al. Role of lactoferrin in immune response and iron homeostasis. Lab Invest. 1999;79(12):1543-54.

9.      Arnold RR, Cole MF, McGhee JR. Defensive functions of lactoferrin. Science. 1977;197(4300):263-5.

10.  Steijns JM, van Hooijdonk AC. The role of milk-derived lactoferrin in health. Br J Nutr. 2000;84 Suppl 1

11.  .

12.  Conneely OM. Lactoferrin: A multifunctional protein. Biochem Cell Biol. 2001;79(3):225-41.

13.  Bullen JJ. Lactoferrin and defense against infection. J Appl Microbiol. 2005;98(6):1296-304.

14.  Park JH, Park JH, Lee JS. Therapeutic potential of lactoferrin in inflammatory diseases. Mol Nutr Food Res. 2010;54(8):1146-52.

15.  Shimazaki K. Structure and function of lactoferrin in various biological systems. Food Sci Technol Res. 2000;6(4):268-73.

16.  Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin and lactoferrin-derived peptides. Clin Microbiol Rev 2009;22(2):465-92.

17.  Dial EJ, Lichtenberger LM. Lactoferrin as a therapeutic agent. Curr Gastroenterol Rep. 2009;11(5):368-74.

18.  Wang B, Timilsena YP, Blanch E, Adhikari B. Lactoferrin: Structure, function, and applications. Compr Rev Food Sci Food Saf. 2019;18(2):495-524.

19.  Lang J, Yang N, Deng J, Liu K, Yang Y, Liu J. Antimicrobial and immunomodulatory functions of lactoferrin. BioMetals. 2018;31(3):367-81.

20.  Perraudin JP. The therapeutic potential of lactoferrin in infectious and inflammatory diseases. Arch Biochem Biophys. 2022;700:108775.

21.  Orsi N. Lactoferrin as a natural immune modulator. Biochem Cell Biol. 2004;82(4):479-84.

22.  Barros SC, Amaral SS, Moreno V, et al. Lactoferrin in immunology and inflammation. Mol Immunol. 2021;136:50-7.

23.  Mandal C, Phukan R, Chaudhary A, Mandal C. Therapeutic implications of lactoferrin in various clinical conditions. Biochimie. 2019;157:41-52.

24.  Jenssen H, Hancock RE. Antimicrobial peptides and lactoferrin in immune defense. Clin Microbiol Rev 2009;22(2):465-92.

25.  Wakabayashi H, Takase M, Hironaka Y, et al. Lactoferrin in host defense against infections. Curr Pharm Des. 2005;11(8):988-98.

26.  Berlutti F, Schippa S, Morea C, et al. Antimicrobial and immunomodulatory functions of lactoferrin. Immunol Lett. 2011;135(1-2):1-12.

27.  Kany AM, Vollrath JT, Relja B. Potential therapeutic applications of lactoferrin. Int J Mol Sci. 2019;20(16):3988.

28.  Alexander DB, Iigo M, Yamauchi K, et al. Lactoferrin and cancer prevention. Biochem Cell Biol. 2012;90(3):377-80.

29.  Zimecki M, Artym J. Immunomodulatory effects of lactoferrin. Adv Clin Exp Med. 2015;24(6):1015-24.

30.  Safaeian L, Vaseghi G, Rezaee M, et al. The role of lactoferrin in metabolic disorders. J Diabetes Metab Disord. 2022;21(1):11-8.

31.  Furmanski P, Li Z, Fortuna MB, et al. Lactoferrin as a cancer therapeutic. Nature. 1989;341(6244):721-3.

32.  Hablass FH, Lashen SA, Alsayed EA. Efficacy of lactoferrin with standard triple therapy or sequential therapy for Helicobacter pylori eradication: A randomized controlled trial. Turk J Gastroenterol. 2021;32(9):742-9.

33.  Takayama T, Aiba Y, Shibuya K, Yamada T, Yajima T, Matsuzaki T. Potent anti-obesity effect of enteric-coated lactoferrin: Decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 2010;104(11):1688-95.

34.  Mohamed WA, Shaalan MF. Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathway. Diabetol Metab Syndr. 2018;10:89.

35.  Ohradanova-Repic A, Praženicová R. Time to kill and time to heal: The multifaceted role of lactoferrin and lactoferricin in host defense. Pharmaceutics. 2023;15(4):1056.

36.  Kozu T, Iinuma G, Ohashi Y, Saito Y, Akasu T, Saito D, Alexander DB, Iigo M, Kakizoe T, Tsuda H. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila). 2009;2(11):975-83.

37.  Alvarez G, Aguilera O, Alcamí J. Comparison of sulfate and lactoferrin effects on viral and bacterial pathogens in children with iron deficiency anemia. Pediatr Res. 2022;92:896-904.

38.  Britigan BE, Ratcliffe C, DeLisle DM, et al. Interactions between lactoferrin and lysozyme in the inhibition of bacterial growth. J Immunol. 1994;152(6):2970-9.

39.  Sahin M, Cansu A, Yavasoglu I, et al. The role of lactoferrin in infectious disease prevention and treatment. Cell Mol Biol (Noisy-le-grand). 2017;63(12):118-23.

40.  Weinberg ED. Lactoferrin's role in cancer therapy. Cancer Res. 1996;56(17):4260-4.

41.  Iigo M, Alexander DB, Long N, et al. Lactoferrin as a therapeutic agent in cancer. Biochem Cell Biol. 2012;90(3):377-80.

42.  Suzuki YA, Lonnerdal B. Lactoferrin and host immune defense. Adv Nutr. 2004;15(4):258-63.

43.  Zimecki M, Artym J, Kocięba M, et al. Antimicrobial and immune-enhancing activities of lactoferrin. Adv Exp Med Biol. 2018;1111:91-102.

44.  Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, et al. Lactoferrin's impact on immune responses. Int J Mol Sci. 2014;15(3):14428-46.

45.  Legrand D, Elass E, Carpentier M, Mazurier J. Role of lactoferrin in iron metabolism and infection control. Biochimie. 2006;88(9):1212-22.

46.  Berlutti F, Valenti P, Rosa L, et al. Potential therapeutic applications of lactoferrin. Front Immunol. 2019;10:917.

47.  Berlutti F, et al. Immunomodulatory effects of lactoferrin in infectious diseases. Curr Pharm Des. 2005;11(8):988-98.

48.  Kawasaki Y, Isoda H, Tada H, et al. Antimicrobial mechanisms of lactoferrin. J Vet Med Sci. 2000;62(7):713-7.

49.  Weinberg ED. Nutritional immunity: The role of lactoferrin in defense. FEMS Immunol Med Microbiol. 2002;34(2):123-7.

50.  Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I. Lactoferrin's role in cellular protection. Biochem Cell Biol. 2006;84(3):303-11.

51.  Sahin M, Cansu A, Yavasoglu I, et al. Lactoferrin's influence on immunity and health. Cell Mol Biol (Noisy-le-grand). 2017;63(12):118-23.

52.  Tomita M, Wakabayashi H, Shin K, et al. Mechanisms of lactoferrin's antimicrobial action. Biochimie. 2009;91(1):52-60.

53.  Gifford JL, Hunter HN, Vogel HJ. Lactoferrin's therapeutic potential. Cell Mol Life Sci. 2005;62(22):2588-98.

54.  Chen J, McLandsborough L, Walker SL. Biofilm inhibition by lactoferrin. J Appl Microbiol. 2013;115(6):1477-85.

55.  Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin in human health. Biometals. 2002;15(3):225-35.

56.  Alexander DB, Iigo M, Yamauchi K, et al. Lactoferrin's anti-cancer activity. Biochem Cell Biol. 2012;90(3):377-80.

57.  Yin J, Xu Y, Wang J, et al. Lactoferrin and chronic diseases. Food Sci Technol Res. 2018;24(1):1-12.

58.  Kany AM, et al. Role of lactoferrin in metabolic disorders. Int J Mol Sci. 2019;20(16):3988.

59.  Tomita M, et al. The potential of lactoferrin in clinical applications. Biochimie. 2009;91(1):52-60.

60.  Furmanski P, Li Z, Fortuna MB, et al. Lactoferrin's role in cancer therapy. Nature. 1989;341(6244):721-3.

61.  Valenti P, Rosa L, Caprio M, et al. Lactoferrin in immune modulation. Int J Mol Sci. 2019;20(19):4660.

62.  Berlutti F, et al. Lactoferrin in microbial defense. Curr Protein Pept Sci. 2004;5(5):451-6.

63.  Selsted ME, Ouellette AJ. Defensive properties of lactoferrin. Nat Immunol. 2005;6(6):551-7.

64.  Wang Y, Li H, Li P, et al. Lactoferrin in gut health. J Dairy Sci. 2018;101(1):776-85.

65.  Zimecki M, Artym J, Chodaczek G. Lactoferrin in immune modulation. Postepy Hig Med Dosw. 2008;62:681-7.

66.  Kawasaki Y, et al. Immunological benefits of lactoferrin. J Vet Med Sci. 2000;62(7):713-7.

67.  Weinberg ED. Role of lactoferrin in immunity. FEMS Immunol Med Microbiol. 2002;34(2):123-7.

68.  Sahin M, et al. Immune defense roles of lactoferrin. Cell Mol Biol (Noisy-le-grand). 2017;63(12):118-23.

69.  Tomita M, et al. Antimicrobial action of lactoferrin. Biochimie. 2009;91(1):52-60.

70.  Gifford JL, Hunter HN, Vogel HJ. Lactoferrin as a therapeutic molecule. Cell Mol Life Sci. 2005;62(22):2588-98.

71.  Berlutti F, et al. Immunomodulatory effects of lactoferrin. Curr Protein Pept Sci. 2004;5(5):451-6.

72.  Kanwar JR, et al. Lactoferrin in cancer therapy. J Exp Clin Cancer Res. 2008;27(1):8.

73. Mohamed WA, Shaalan MF. Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathway. Diabetol Metab Syndr. 2018;10:89.